Recent insights into neurofibromatosis type 1: Clear genetic progress

Archives of Neurology

Volumn 55, Issue 6, 1998, Pages 778-780

  Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BONE DYSPLASIA; GLIOMA; HUMAN; LEARNING DISORDER; NEUROFIBROMA; NEUROFIBROMATOSIS; PREVALENCE; PRIORITY JOURNAL; PSEUDARTHROSIS;

ADULT; CHILD; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; LEARNING DISORDERS; NEUROFIBROMA; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS; PEDIGREE; RESEARCH;

EID: 0031781667     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.6.778     Document Type: Article

References (16)

1. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51-57.
2. North KK, Riccardi V, Samango-Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology. 1997;48:1121-1127.
3. North K, Joy P, Yuille D, et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology. 1994;44: 878-883.
4. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology. 1996;46:1660-1668.
5. Danglot G, Regnier V, Fauvet D, Vassal G, Kujas M, Bernheim A. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet. 1995;4:915-920.
6. Geist RT, Gutmann DH. Expression of a developmentally-regulated neuronspecific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett. 1996; 211:85-88.
7. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell. 1995;82:733-742.
8. Silva AJ, Frankland PW, Marowitz Z, et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type 1. Nat Genet. 1997;15: 281-284.
9. The I, Hannigan GE, Cowley GS, Reginald S, et al. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science. 1997;276:791-794.
10. Guo H-F, The I, Hannan F, Bernards A, Zhong Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science. 1997; 276:795-798.
11. Listernick R, Louis DN, Packer PJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol. 1997;41:143-149.
12. Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res. 1996;43:246-253.
13. Nordlund ML, Rizvi TA, Brannan CI, Ratner N. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol. 1995; 54:588-600.
14. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet. 1996; 14:110-112.
15. Kim HA, Ling B, Ratner N. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farsenyl protein transferase. Mol Cell Biol. 1997;17:862-872.
16. Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE. Schwann cells from neurofibromin-deficient mice exhibit activation of p21-ras, inhibition of cell proliferation and morphological changes. Oncogene. 1995;11:325-335.